Radient Technologies Inc. Signs Supply Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc., ...
February 11 2020 - 4:15PM
Radient Technologies Inc. (“Radient” or the
“Company”) (
TSX Venture: RTI; OTCQX: RDDTF), a
global manufacturer of high quality cannabinoid-based ingredients,
formulations and products, is pleased to announce it has entered
into a supply agreement (the “Agreement”) with Medical Cannabis by
Shoppers, the online medical cannabis platform of leading Canadian
pharmacy retailer Shoppers Drug Mart (“Shoppers”).
Under the terms of the Agreement, Radient will
utilize its proprietary extraction and downstream processing
platform to create a variety of cannabinoid formulations under a
brand that will be sold exclusively to patients of Medical Cannabis
by Shoppers. The Agreement is for a three-year term, subject to
renewal for an additional two years or earlier
termination.
Radient’s unique, continuous-flow extraction
process has been proven to achieve a higher recovery of active
compounds from the cannabis plant (up to 99%) than other extraction
methods, has lower risk of cannabinoid degradation during
processing which allows products to maintain stability (“shelf
life”) for a longer period of time, and has a high level of product
consistency. Combining its unique extraction technology with
stringent quality control systems and decades of botanical
ingredient manufacturing experience, Radient produces a variety of
broad spectrum cannabinoid formulations, ingredients and products
that meet the highest standards of quality and safety.
Denis Taschuk, President & CEO of Radient
commented, “This is an incredible milestone for Radient. We are
very proud of what we have achieved as a Company over the last two
years, and this partnership is a monumental leap forward. We are
very pleased to be supplying Medical Cannabis by Shoppers with
unique formulations and products that meet the highest standards of
quality and safety, and we look forward to working with them.”
About Radient Radient
Technologies is a commercial manufacturer of high quality
cannabinoid based formulations, ingredients and products. Utilizing
a proprietary extraction and downstream processing platform that
recovers up to 99% of cannabinoids from the cannabis plant, Radient
develops specialty products and ingredients that contain a broad
range of cannabinoid and terpene profiles while meeting the highest
standards of quality and safety. Please visit www.radientinc.com
for more information.
SOURCE: Radient Technologies Inc.
Investors please contact: Adam Deffett, Sr. VP Corporate
Development: adeffett@radientinc.com
Media/press please contact: Caitlin Cheadle, Director of
Communications: ccheadle@radientinc.com
Forward Looking Information:
This press release contains “forward-looking information” within
the meaning of applicable Canadian securities legislation.
Forward-looking information includes, without limitation,
statements regarding the growth of the Company’s business
operations; the Company’s ability to grow its business in the
cannabis sector including pursuant to the Agreement and the
Company’s future plans. Generally, forward-looking information can
be identified by the use of forward-looking terminology such as
“plans”, “expects” or “does not expect”, “is expected”, “budget”,
“scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or
“does not anticipate”, or “believes”, or variations of such words
and phrases or state that certain actions, events or results “may”,
“could”, “would”, “might” or “will be taken”, “occur” or “be
achieved”. Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
Radient, as the case may be, to be materially different from those
expressed or implied by such forward-looking information. Although
Radient has attempted to identify important factors that could
cause actual results to differ materially from those contained in
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such information will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking information. Radient does
not undertake to update any forward-looking information, except in
accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Oct 2023 to Oct 2024